Altered uterine contractility in response to β-adrenoceptor agonists in ovarian cancer

[1]  B. Modzelewska.  Beta-adrenoceptors in obstetrics and gynecology. , 2016, Developmental period medicine.

[2]  A. Sood,et al.  Clinical impact of selective and nonselective beta‐blockers on survival in patients with ovarian cancer , 2015, Cancer.

[3]  T. Dowswell,et al.  Combination of tocolytic agents for inhibiting preterm labour. , 2014, The Cochrane database of systematic reviews.

[4]  F. Kagitani,et al.  Autonomic nervous regulation of ovarian function by noxious somatic afferent stimulation , 2014, The Journal of Physiological Sciences.

[5]  Mustafa B. A. Djamgoz,et al.  Regulation of voltage-gated sodium channel expression in cancer: hormones, growth factors and auto-regulation , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[6]  C. Cho,et al.  β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy. , 2013, Seminars in cancer biology.

[7]  Yan-lai Sun,et al.  Role of the nervous system in cancer metastasis , 2013, Oncology letters.

[8]  S. Mishra,et al.  Molecular and functional characteristics of β3-adrenoceptors in late pregnant mouse uterus: a comparison with β2-adrenoceptors. , 2013, European journal of pharmacology.

[9]  Steven W. Cole,et al.  Molecular Pathways: Beta-Adrenergic Signaling in Cancer , 2011, Clinical Cancer Research.

[10]  B. Modzelewska,et al.  Differences in the effects of beta2- and beta3-adrenoceptor agonists on spontaneous contractions of human nonpregnant myometrium. , 2011, Ginekologia polska.

[11]  A. Sood,et al.  Stress Influences on Anoikis , 2011, Cancer Prevention Research.

[12]  B. Goff,et al.  Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability. , 2011, Gynecologic oncology.

[13]  F. Penedo,et al.  Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients , 2011, Brain, Behavior, and Immunity.

[14]  Jing Cai,et al.  Expression of voltage-gated sodium channel alpha subunit in human ovarian cancer. , 2010, Oncology reports.

[15]  P. Sagot,et al.  SAR150640, a selective β3‐adrenoceptor agonist, prevents human myometrial remodelling and activation of matrix metalloproteinase in an in vitro model of chorioamnionitis , 2010, British journal of pharmacology.

[16]  Naveena Singh,et al.  Synchronous tumours of the female genital tract , 2010, Histopathology.

[17]  B. Modzelewska,et al.  Influence of potent and selective beta-adrenoceptor agonist, CL 316243, on the contractile response of non-pregnant human myometrium. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[18]  R. Fischmeister,et al.  beta3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2+ current. , 2008, The Journal of clinical investigation.

[19]  A. Sood,et al.  Neuroendocrine influences on cancer biology. , 2008, Seminars in cancer biology.

[20]  M. Leroy,et al.  In Vitro and in Vivo Pharmacological Characterization of Ethyl-4-{trans-4-[((2S)-2-hydroxy-3-{4-hydroxy-3[(methylsulfonyl)amino]-phenoxy}propyl) Amino]cyclohexyl}benzoate Hydrochloride (SAR150640), a New Potent and Selective Human β3-Adrenoceptor Agonist for the Treatment of Preterm Labor , 2007, Journal of Pharmacology and Experimental Therapeutics.

[21]  T. Tan,et al.  Tocolytic treatment for the management of preterm labour: a systematic review. , 2006, Singapore medical journal.

[22]  M. Tateyama,et al.  Sustained beta-adrenergic stimulation increased L-type Ca2+ channel expression in cultured quiescent ventricular myocytes. , 2006, The journal of physiological sciences : JPS.

[23]  T. Erselcan,et al.  Comparison of effects of formoterol and BRL 37344 on isolated term-pregnant rat myometrial strips in vitro. , 2006, European journal of pharmacology.

[24]  Terry J. Smith,et al.  Functional coupling of beta3-adrenoceptors and large conductance calcium-activated potassium channels in human uterine myocytes. , 2005, The Journal of clinical endocrinology and metabolism.

[25]  I. Messinis,et al.  In vitro responsiveness of human post-menopausal myometrium to endothelin-1 and ovarian steroids , 2005, Journal of endocrinological investigation.

[26]  R. Khan,et al.  Contribution of coupling between human myometrial beta2-adrenoreceptor and the BK(Ca) channel to uterine quiescence. , 2004, American journal of physiology. Cell physiology.

[27]  A. Sood,et al.  Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  T. Kawarabayashi,et al.  Diversity of inhibitory responses to beta2-stimulants shown by term-pregnant human myometria in vitro is partly due to differences in receptor density. , 2002, American journal of obstetrics and gynecology.

[29]  R. Fanchin,et al.  Contractility of the Nonpregnant Uterus , 2001, Annals of the New York Academy of Sciences.

[30]  J. Saavedra,et al.  Involvement of K+ATP channels in nitric oxide-induced inhibition of spontaneous contractile activity of the nonpregnant human myometrium. , 1998, Biochemical and biophysical research communications.

[31]  John J. Peterson,et al.  Estimation of Confidence Intervals for Area Under the Curve from Destructively Obtained Pharmacokinetic Data , 1998, Journal of Pharmacokinetics and Biopharmaceutics.

[32]  J. Morrison,et al.  Ca2+ dependence and pharmacology of large-conductance K+ channels in nonlabor and labor human uterine myocytes. , 1997, The American journal of physiology.

[33]  H. Izumi,et al.  EFFECTS OF RITODRINE, A β2‐ADRENOCEPTOR AGONIST, ON SMOOTH MUSCLE CELLS OF THE MYOMETRIUM OF PREGNANT RATS , 1982, British journal of pharmacology.

[34]  D. Tredway,et al.  Sperm transport from the external cervical os to the fallopian tubes in women: a time and quantitation study. , 1973, Fertility and sterility.

[35]  A. Scilimati,et al.  β(3)-Adrenoceptor agonists and (antagonists as) inverse agonists history, perspective, constitutive activity, and stereospecific binding. , 2010, Methods in enzymology.

[36]  Peter Devilee,et al.  Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2003 .